Medtronic plc - IE00BTN1Y115 - Предложение об обмене

АО "ФИНАМ" сообщает, что поступила информация от СПБ БАНК АО о корпоративном действии «Предложение об обмене»

Реквизиты корпоративного действия
Референс корпоративного действия	1688729788
Код типа корпоративного действия	EXOF
Тип корпоративного действия	Предложение об обмене
Признак обязательности КД	VOLU - Участие в корпоративном действии добровольное; от владельца счета требуются дополнительные инструкции
Статус обработки	Обработка информации о корпоративном действии завершена Возникновение события было подтверждено

Информация о ценных бумагах
Референс КД по ценной бумаге	Эмитент	Наименование ценной бумаги	Категория	ISIN	Номинальная стоимость
1688729788BNYDTC	Medtronic plc		Акции	IE00BTN1Y115

Детали корпоративного действия

Варианты корпоративного действия
Номер варианта корпоративного действия	001
Признак варианта корпоративного действия	NOAC Вариант, когда владелец счета не участвует в корпоративном событии, включая отказ от группового иска или предъявления прав.
Флаг обработки по умолчанию	Да
Последний срок ответа	08.10.2026 13:00:00

Дополнительная информация, уточняющая содержание сообщения

THE FOLLOWING PREVIOUSLY ANNOUNCED CORPORATE EVENT HAS NOW BEEN UPDATED/COMPLETED EVENT TYPE : EXCHANGE OFFICIAL CORPORATE ACTION EVENT REFERENCE : US158335344 PAYMENT DATE : Unknown EXPECTED TO RECEIVE DATE : Unknown EXPIRY DATE (COMPANY/REGISTRAR) : 09-Oct-26 23.59.59 ACCRUED INTEREST INDICATOR : No RESTRICTION FLAG : No OPTION AND PAYOUT DETAILS : 001-ACCEPT THE SECURITY OFFER OPTION DESCRIPTION : EXCHANGE ODD LOT OPTION FEATURE : Odd Lot Preference DEFAULT OPTION INDICATOR : NO CUSDAR OPTION STATUS : Active MARKET DEADLINE DATE : 09-Oct-26 23.59.59 DEPOSITORY COVER EXPIRY DATE : 13-Oct-2026 WITHDRAWL ALLOW INDICATOR : YES REVOCABILITY START DATE : 18-Sep-2026 REVOCABILITY END DATE : 09-Oct-2026 PROTECT END DATE : 09-Oct-2026 OPTION START DATE : 18-Sep-2026 00.00.00 OPTION END DATE : 09-Oct-2026 00.00.00 SECURITY OFFER DEBIT CREDIT INDICATOR : CREDIT NEW SEC ID (ISIN) : Unknown SECURITY OFFER FORM : RATIO SECURITY OFFER DEBIT CREDIT INDICATOR : DEBIT NEW SECURITY NAME : MEDTRONIC PLC USD 0.1 SECURITY OFFER FORM : RATIO SECURITY OFFER NUMERATOR : 1.0 SECURITY OFFER DENOMINATOR : 1.0 SECURITY OFFER RATIO : 1.0 SECURITY OFFER DEBIT CREDIT INDICATOR : CREDIT NEW SEC ID (ISIN) : Unknown SECURITY OFFER FORM : RATIO 002-TAKE NO ACTION DEFAULT OPTION INDICATOR : YES CUSDAR OPTION STATUS : Active 003-ACCEPT THE SECURITY OFFER OPTION DESCRIPTION : EXCHANGE NON-ODD LOT DEFAULT OPTION INDICATOR : NO CUSDAR OPTION STATUS : Active MARKET DEADLINE DATE : 09-Oct-26 23.59.59 DEPOSITORY COVER EXPIRY DATE : 13-Oct-2026 WITHDRAWL ALLOW INDICATOR : YES REVOCABILITY START DATE : 17-Sep-2026 REVOCABILITY END DATE : 09-Oct-2026 PROTECT END DATE : 09-Oct-2026 OPTION START DATE : 17-Sep-2026 00.51.56 OPTION END DATE : 09-Oct-2026 18.00.00 SECURITY OFFER DEBIT CREDIT INDICATOR : CREDIT NEW SEC ID (ISIN) : Unknown SECURITY OFFER FORM : RATIO SECURITY OFFER DEBIT CREDIT INDICATOR : DEBIT NEW SECURITY NAME : MEDTRONIC PLC USD 0.1 SECURITY OFFER FORM : RATIO SECURITY OFFER NUMERATOR : 1.0 SECURITY OFFER DENOMINATOR : 1.0 SECURITY OFFER RATIO : 1.0 FREE FORMAT TEXT OF EVENT : +++UPDATE AS OF 08OCT2026+++ . MEDTRONIC PLC ON OCTOBER 7, 2026 ANNOUNCED THE FINAL EXCHANGE RATIO OF 4.5939 SHARES OF MINIMED GROUP, INC. COMMON STOCK FOR EACH MEDTRONIC ORDINARY SHARE VALIDLY TENDERED AND ACCEPTED IN ITS SPLIT-OFF EXCHANGE OFFER, FIXING THE RATIO AT THE OFFERS UPPER LIMIT AFTER THE FINAL CALCULATED PER-SHARE VALUES OF THE TWO STOCKS WOULD HAVE PRODUCED AN EXCHANGE RATIO ABOVE IT. . PLEASE USE THE LINK BELOW (CASE SENSTIVE) TO REVIEW THE PRESS RELEASE. https://www.securities.io/medtronic-sets-minimed-split-off-exchange-ra tio-at-4-5939-upper-limit/ . +++END OF UPDATE+++ +++UPDATE AS OF 17SEP2026+++ . HOLDERS ARE ADVISED THAT THE COMPANY HAS AMENDED THE COVER PROTECT EXPIRATION DATE. PLEASE REFER TO THE FORM 8-K, WHICH WILL BE FILED BY THE COMPANY, FOR MORE INFORMATION. . +++END OF UPDATE+++ +++UPDATE AS ON 17 SEPTEMBER 2026+++ . TERMS AND OPTIONS HAVE BEEN CONFIRMED. . +++ THE OFFER IS SUBJECT TO CERTAIN JURISDICTIONAL RESTRICTIONS AS DEFINED IN THE OFFERING MATERIALS. HOLDERS SHOULD REFER TO THE OFFERING MATERIALS FOR COMPLETE DETAILS.+++ HOLDERS ARE ADVISED PARTICIPATING IN THIS OFFER, CONSTITUTES YOUR REPRESENTATION THAT YOU HAVE REVIEWED ALL OF THE OFFERING MATERIALS AND THAT YOU ARE ELIGIBLE TO PARTICIPATE IN THE ACTION AND COMPLY WITH ANY PARTICIPATION RESTRICTIONS. . HOLDERS ARE ADVISED THAT STANDING INSTRUCTIONS FOR THE OPTIONS WILL NOT APPLY FOR THIS EVENT. FX STANDING INSTRUCTIONS REMAIN VALID. HOLDERS WHO WISH TO HAVE AN ELECTION APPLIED TO THIS EVENT MUST SUBMIT A RESPONSE ACCORDINGLY. OPTION 1 ODD LOT OPTION 2 NO ACTION OPTION 3 SECURITY . MEDTRONIC PLC, AN IRISH PUBLIC LIMITED COMPANY (MEDTRONIC), IS OFFERING TO EXCHANGE (THE EXCHANGE OFFER) UP TO AN AGGREGATE OF 225,361,295 NEWLY ISSUED SHARES OF COMMON STOCK, PAR VALUE USD 0.01 PER SHARE (MINIMED COMMON STOCK), OF MINIMED GROUP, INC., A DELAWARE CORPORATION (MINIMED), FOR OUTSTANDING ORDINARY SHARES, PAR VALUE USD 0.0001 PER SHARE (MEDTRONIC ORDINARY SHARES), OF MEDTRONIC THAT ARE VALIDLY TENDERED AND NOT VALIDLY WITHDRAWN. IN ADDITION, IF THE EXCHANGE OFFER IS OVERSUBSCRIBED, MEDTRONIC MAY, WITHOUT EXTENDING THE EXCHANGE OFFER PERIOD, DECIDE TO ACCEPT AN ADDITIONAL NUMBER OF MEDTRONIC ORDINARY SHARES THAT ARE VALIDLY TENDERED AND NOT VALIDLY WITHDRAWN NOT TO EXCEED TWO PERCENT OF THE TOTAL OUTSTANDING MEDTRONIC ORDINARY SHARES (THE DE MINIMIS INCREASE AMOUNT). IF THE EXCHANGE OFFER IS OVERSUBSCRIBED, MEDTRONIC CURRENTLY INTENDS TO ACCEPT AN ADDITIONAL NUMBER OF MEDTRONIC ORDINARY SHARES NOT TO EXCEED THE DE MINIMIS INCREASE AMOUNT CONSTITUTING ALL OF MEDTRONICS REMAINING INTEREST IN MINIMED. . THIS EXCHANGE OFFER IS INTENDED TO PERMIT YOU TO EXCHANGE YOUR MEDTRONIC ORDINARY SHARES FOR SHARES OF MINIMED COMMON STOCK AT A 7 PCT DISCOUNT TO THE PER-SHARE MARKET VALUE OF MINIMED COMMON STOCK THROUGH AN EXCHANGE RATIO CALCULATED AS SET FORTH IN THIS PROSPECTUS, SUBJECT TO THE UPPER LIMIT DESCRIBED BELOW. FOR EACH USD 100 OF MEDTRONIC ORDINARY SHARES ACCEPTED IN THIS EXCHANGE OFFER, YOU WILL RECEIVE APPROXIMATELY USD 107.53 OF MINIMED COMMON STOCK, SUBJECT TO AN UPPER LIMIT OF 4.5939 SHARES OF MINIMED COMMON STOCK PER MEDTRONIC ORDINARY SHARE. THIS EXCHANGE OFFER DOES NOT PROVIDE FOR A LOWER LIMIT OR MINIMUM EXCHANGE RATIO. SEE THE EXCHANGE OFFER-TERMS OF THE EXCHANGE OFFER. IF THE UPPER LIMIT IS IN EFFECT, YOU MAY RECEIVE LESS THAN USD 107.53 OF MINIMED COMMON STOCK FOR EACH USD 100 OF MEDTRONIC ORDINARY SHARES THAT YOU TENDER, AND YOU COULD RECEIVE MUCH LESS. . THE VALUE OF THE MEDTRONIC ORDINARY SHARES AND THE MINIMED COMMON STOCK FOR PURPOSES OF THE PRECEDING PARAGRAPH AND THIS EXCHANGE OFFER WILL BE DETERMINED BY REFERENCE TO THE SIMPLE ARITHMETIC AVERAGE OF THE DAILY VOLUME-WEIGHTED AVERAGE PRICES (VWAPS) OF MEDTRONIC ORDINARY SHARES (THE AVERAGE MDT PRICE) ON THE NEW YORK STOCK EXCHANGE (THE NYSE) AND MINIMED COMMON STOCK (THE AVERAGE MMED PRICE) ON THE NASDAQ GLOBAL SELECT MARKET (NASDAQ) DURING THE THREE CONSECUTIVE TRADING DAYS ENDING ON AND INCLUDING THE SECOND TRADING DAY PRECEDING THE EXPIRATION DATE OF THE EXCHANGE OFFER (THE AVERAGING DATES AND THIS THREE-DAY PERIOD, THE AVERAGING PERIOD), WHICH, IF THE EXCHANGE OFFER IS NOT EXTENDED OR TERMINATED, WOULD BE OCTOBER 5, OCTOBER 6, AND OCTOBER 7, 2026. SEE THE EXCHANGE OFFER-TERMS OF THE EXCHANGE OFFER. THE EXCHANGE RATIO WILL VALUE MEDTRONIC ORDINARY SHARES AT 100 PCT OF THE AVERAGE MDT PRICE AND WILL VALUE MINIMED COMMON STOCK AT 93 PCT OF THE AVERAGE MMED PRICE. THEREFORE, THE EXCHANGE RATIO WILL OFFER MINIMED COMMON STOCK AT A DISCOUNT FROM THE MARKET VALUE REFLECTED IN THE AVERAGE MMED PRICE. . HOLDER SHOULD NOT COMBINE ODD LOT INSTRUCTIONS WITH ROUND LOT INSTRUCTIONS. HOLDERS MUST PROVIDE A BENEFICIAL HOLDER BREAKDOWN WHEN RESPONDING. THIS BREAKDOWN SHOULD CONSIST OF (1) THE TOTAL NUMBER OF BENEFICIAL HOLDERS AND (2) THE NUMBER OF SHARES HELD PER BENEFICIAL HOLDER. NO ADDITIONAL INFORMATION IS REQUIRED. HOLDERS ARE ADVISED THAT HOLDERS WHO BENEFICIALLY OWN ODD-LOTS (LESS THAN 100 SHARES) AND WHO VALIDLY TENDER ALL OF THEIR SHARES WILL NOT BE SUBJECT TO PRORATION. PLEASE REFER TO THE QUESTION AND ANSWERS ABOUT THE EXCHANGE OFFER SECTION WITHIN THE OFFERING DOCUMENT FOR DETAILS REGARDING PRORATION ACCEPTANCE. . IN THAT CASE, ALL MEDTRONIC ORDINARY SHARES THAT ARE VALIDLY TENDERED AND NOT VALIDLY WITHDRAWN WILL GENERALLY BE ACCEPTED FOR EXCHANGE ON A PRO RATA BASIS IN PROPORTION TO THE NUMBER OF SHARES VALIDLY TENDERED, WHICH IS REFERRED TO AS PRORATION. MEDTRONIC SHAREHOLDERS HAVE VALIDLY TENDERED MORE MEDTRONIC ORDINARY SHARES THAN MEDTRONIC ACCEPTS FOR EXCHANGE, MEDTRONIC WILL ACCEPT FOR EXCHANGE THE MEDTRONIC ORDINARY SHARES VALIDLY TENDERED AND NOT VALIDLY WITHDRAWN BY EACH TENDERING SHAREHOLDER ON A PRO RATA BASIS, BASED ON THE PROPORTION THAT THE TOTAL NUMBER OF MEDTRONIC ORDINARY SHARES TO BE ACCEPTED FOR EXCHANGE BEARS TO THE TOTAL NUMBER OF MEDTRONIC ORDINARY SHARES VALIDLY TENDERED AND NOT VALIDLY WITHDRAWN (ROUNDED TO THE NEAREST WHOLE NUMBER OF MEDTRONIC ORDINARY SHARES AND SUBJECT TO ANY ADJUSTMENT NECESSARY TO ENSURE THE EXCHANGE OF ALL SHARES OF NEWLY ISSUED MINIMED COMMON STOCK BEING OFFERED IN THE EXCHANGE OFFER), EXCEPT FOR TENDERS OF ODD-LOTS. EXCEPT AS OTHERWISE PROVIDED IN THIS SECTION, BENEFICIAL HOLDERS OF LESS THAN 100 MEDTRONIC ORDINARY SHARES WHO VALIDLY TENDER ALL OF THEIR SHARES WILL NOT BE SUBJECT TO PRORATION IF THE EXCHANGE OFFER IS OVERSUBSCRIBED. DIRECT OR BENEFICIAL HOLDERS OF 100 OR MORE MEDTRONIC ORDINARY SHARES, AND THOSE WHO OWN LESS THAN 100 SHARES BUT DO NOT TENDER ALL OF THEIR SHARES, WILL BE SUBJECT TO PRORATION. . HOLDERS SHOULD CONSULT THEIR TAX ADVISOR FOR COMPLETE DETAILS IN REFERENCE TO WITHHOLDING TAXES. . THERE IS GUARANTEE OF DELIVERY (PROTECT) AFFORDED TO THIS OFFER. . THE EXCHANGE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME, AT THE END OF THE DAY ON OCTOBER 9, 2026, UNLESS THE EXCHANGE OFFER IS EXTENDED OR TERMINATED. . DTC WILL EXPIRE AT 6:00 P.M., NEW YORK CITY TIME ON OCTOBER 9, 2026. . HOLDERS SHOULD OBTAIN THE PROSPECTUS DATED SEPTEMBER 14, 2026, FOR COMPLETE DETAILS OF THE OFFER. . MATERIALS ARE AVAILABLE FOR DOWNLOAD IN OUR NEXEN CA PORTAL OR UPON REQUEST. . +++END OF UPDATE+++ . CONTACT INFORMATION FOR THE INFORMATION AGENT IS: D.F. KING SHAREHOLDERS CALL: (877) 361-7972 BANKS, BROKERS, AND ALL OTHERS OUTSIDE THE UNITED STATES CALL: (646) 845-0146 EMAIL: MINIMED(AT)DFKING.COM . +++INFO AS OF 16SEP2026+++ . HOLDERS ARE ADVISED THAT THIS EVENT WILL BE UPDATED UPON RECEIVING FURTHER INFORMATION. . +++END OF UPDATE+++ OFFEROR : MEDTRONIC PLC SHOULD YOU HAVE ANY QUESTIONS CONCERNING THIS ADVICE, PLEASE CONTACT THE BANK OF NEW YORK. CONTACT NAME : APAC based clients:GCEAPAC(AT)bny.com OR +1 646 782 6850 EMEA based clients: GCEEMEA(AT)bny.com OR +44 161 687 4545 Americas based clients: PS(underscore)CSEInquiries(AT)bny.com OR +1 412 234 0660 DISCLAIMER : PLEASE NOTE THAT BANK OF NEW YORK (BNY) IS NOT EXPECTING ANY FREE TEXT INFORMATION AS PART OF YOUR ELECTION INSTRUCTION FOR BELOW MENTIONED OPTION(S) ON THIS EVENT. IN CASE FREE TEXT IS STILL INCLUDED IN THE INSTRUCTION, BNY IS NOT LIABLE TO REVIEW AND ACT UPON IT. IF YOU HAVE SPECIAL NEED FOR AN INSTRUCTION, PLEASE REACH TO YOUR USUAL BNY CONTACT FOR CORPORATE ACTION. 002-TAKE NO ACTION 003-ACCEPT THE SECURITY OFFER THIS ADVICE IS BASED UPON THE ANNOUNCEMENT OF THIS EVENT IN THE MARKET AND WHICH IS AVAILABLE TO BNY. ALL INFORMATION PROVIDED BY BNY IS DERIVED FROM SOURCES BELIEVED TO BE RELIABLE WITHIN THE INDUSTRY. PLEASE REFER TO ANY OFFERING DOCUMENTS THAT MAY BE AVAILABLE FROM THE ISSUER FOR COMPLETE DETAILS AND OFFERING TERMS. In this notice, BNY refers to the following: The Bank of New York, BNY CSD SA/NV, The Bank of New York SA/NV, The Bank of New York Trust Company, N.A., BNY Asset Servicing, B.V., BNY Trust of Delaware, BNY Trust Company of Illinois, The Bank of New York (International) LTD. (including its Luxembourg Branch), CIBC Mellon Global Securities Services Company and CIBC Mellon Trust Company